One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges
Poonam Yadav a , Sumeet Kumar Singh a , Sonu Rajput a , Prince Allawadhi b , Amit Khurana a,c,?, Ralf Weiskirchen c,?, Umashanker Navik
doi : 10.1016/j.pharmthera.2023.108563
Volume 253, January 2024, 108563
Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions
Salam Salloum-Asfar ?, Nasser Zawia, Sara A. Abdulla ?
doi : 10.1016/j.pharmthera.2023.108564
Volume 253, January 2024, 108564
Repurposing of pexidartinib for microglia depletion and renewal
Marc-Philipp Weyer a , Jenny Strehle b , Michael K.E. Sch?fer b , Irmgard Tegeder
doi : 10.1016/j.pharmthera.2023.108565
Volume 253, January 2024, 108565
Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases
Yigan Zhang a,h,1 , Yumei Lei b,1 , Yanbin Dong c,1 , Shuwen Chen d , Siyuan Sun b , Fange Zhou e , Zhiwen Zhao f , Bonan Chen g , Lv Wei c,???, Juan Chen b,??, Zhongji Meng a,h,
doi : 10.1016/j.pharmthera.2023.108576
Volume 253, January 2024, 108576
Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden
Mara Lyon 1 , Josie L. Fullerton 1 , Simon Kennedy, Lorraine M. Work
doi : 10.1016/j.pharmthera.2023.108575
Volume 253, January 2024, 108575
Organic cation transporters in psychiatric and substance use disorders
Lauren E. Honan a , Rheaclare Fraser-Spears b , Lynette C. Daws
doi : 10.1016/j.pharmthera.2023.108574
Volume 253, January 2024, 108574
Clinical advances in TNC delivery vectors and their conjugate agents
Wujun Chen a,1 , Yudong Wu a,1 , Jie Wang a,1 , Wanpeng Yu b , Xin Shen c , Kai Zhao a,d , Bing Liang a , Xiaokun Hu a,e , Shuai Wang f , Hongfei Jiang a , Xinlin Liu a , Miao Zhang a , Xiaohui Xing g,?, Chao Wang a,?, Dongming Xing
doi : 10.1016/j.pharmthera.2023.108577
Volume 253, January 2024, 108577
Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases
Takuma Isshiki a,b,c , Safaa Naiel a,b , Megan Vierhout a,b , Kohei Otsubo a,d , Pareesa Ali a,b , Kazuya Tsubouchi a,d , Parichehr Yazdanshenas a,b , Vaishnavi Kumaran a,b , Anna Dvorkin-Gheva b , Martin R.J. Kolb a , Kjetil Ask
doi : 10.1016/j.pharmthera.2023.108578
Volume 253, January 2024, 108578
TAAR1 as an emerging target for the treatment of psychiatric disorders
Jianfeng Liu a,b,??, Ruyan Wu c , Jun-Xu Li
doi : 10.1016/j.pharmthera.2023.108580
Volume 253, January 2024, 108580
